News Sentiment

MDT sentiment intelligence

Medtronic PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 55 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 83.87 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

74/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

+0.8% over one week, +5.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Medtronic (MDT) Completes SPR Therapeutics Acquisition To Expand Non Opioid Pain Care

Market Reaction

Balanced read

46/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 74/100 classification
One-week reaction 0.8% Price digesting
Trend fit Trend inactive 5.5% over four weeks
Fair value 1.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 33
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 11
Sector context 2

Sources

Coverage mix

Publishers
Market source 15
simplywall.st 6
Stock Titan 4
Kavout | AI 3
Reuters 2
Quiver Quantitative 2
StockStory 2
TradingView 2

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 19
Deals and strategy 9
Regulatory and legal 3
Capital return 2
Analyst action 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 55
Investing.com Direct company coverage

Medtronic completes $650M acquisition of SPR Therapeutics

Medtronic (NYSE: MDT) has finalized its $650 million acquisition of SPR Therapeutics, a company specializing in short-term peripheral nerve stimulation for pain management. This strategic move strengthens Medtronic's presence in the healthcare equipment industry by integrating SP

Tone
Positive 70/100
Event
Deals and strategy
Published
16 Jul 2026 22:08
Source
Investing.com
marketscreener.com Direct company coverage

Medtronic Completes $650 Million Acquisition of SPR Therapeutics

Medtronic has finalized its $650 million acquisition of SPR Therapeutics, a neurostimulation device company. This move is part of Medtronic's strategy to expand its medical equipment portfolio, particularly in the pain management sector. The acquisition is expected to bolster Med

Tone
Positive 70/100
Event
Deals and strategy
Published
16 Jul 2026 13:28
Source
marketscreener.com
Investing.com Canada Direct company coverage

Medtronic completes $650M acquisition of SPR Therapeutics By Investing.com

Medtronic has completed its $650 million acquisition of SPR Therapeutics, a privately held medical technology company specializing in short-term peripheral nerve stimulation therapies for pain management. This acquisition strengthens Medtronic's position in the healthcare equipme

Tone
Positive 67/100
Event
Deals and strategy
Published
16 Jul 2026 13:10
Source
Investing.com Canada
Medtronic Direct company coverage

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Medtronic has completed its acquisition of SPR Therapeutics, Inc. for $650 million, integrating SPR's SPRINT® PNS System into its pain therapy portfolio. This expands Medtronic's offerings for chronic and acute pain management with a minimally invasive, non-opioid treatment that

Tone
Positive 74/100
Event
Deals and strategy
Published
16 Jul 2026 13:04
Source
Medtronic
Stock Titan Direct company coverage

Medtronic Adds 60-Day Pain Therapy Without Permanent Implant

Medtronic (NYSE: MDT) has completed its $650 million cash acquisition of SPR Therapeutics, adding the SPRINT® peripheral nerve stimulation (PNS) technology to its pain therapy portfolio. This acquisition expands Medtronic's offerings for minimally invasive, non-opioid treatments

Tone
Positive 70/100
Event
Deals and strategy
Published
16 Jul 2026 12:59
Source
Stock Titan
Reuters Direct company coverage

Medtronic faces first trial in US hernia mesh injury cases

Medtronic's Covidien unit is facing its first jury trial in Boston over claims that its hernia-repair mesh implants caused injuries. The plaintiff, Larry Patterson, alleges a Symbotex mesh implant led to a bowel obstruction, while Medtronic argues the product worked as designed a

Tone
Negative 28/100
Event
Market update
Published
15 Jul 2026 18:21
Source
Reuters
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD)

Three analysts from Bank of America Securities have provided bullish sentiments on healthcare companies Medtronic (MDT), Quest Diagnostics (DGX), and Gilead Sciences (GILD). Travis Steed maintained a Buy rating on Medtronic with a $95.00 price target, Michael Ryskin kept a Buy ra

Tone
Positive 71/100
Event
Analyst action
Published
15 Jul 2026 04:37
Source
The Globe and Mail
Seeking Alpha Sector context

MedTech stocks lower as HCA surgery volumes dip (HCA:NYSE)

MedTech stocks experienced a downturn following HCA Healthcare's announcement of lowered full-year earnings outlook and a preliminary Q2 2026 report indicating a drop in surgical procedures. This decline in surgical volumes at the largest for-profit hospital operator in the U.S.

Tone
Negative 29/100
Event
Earnings
Published
14 Jul 2026 18:40
Source
Seeking Alpha
TechStock² Sector context

Intuitive Surgical (NASDAQ:ISRG) slides 6%; HCA surgery slowdown sharpens Q2 valuation test

Intuitive Surgical (ISRG) shares dropped 6.2% following HCA Healthcare's report of a slowdown in surgical volumes, raising concerns about ISRG's upcoming Q2 results. Despite analyst target cuts, the stock's valuation remains premium, reflecting expectations for continued growth,

Tone
Negative 28/100
Event
Analyst action
Published
14 Jul 2026 17:49
Source
TechStock²
MarketWatch Direct company coverage

Medtronic PLC stock underperforms Tuesday when compared to competitors

Shares of Medtronic PLC (MDT) fell 5.11% to $79.30 on Tuesday, despite a generally positive trading session for the broader market, with both the S&P 500 and Dow Jones Industrial Average posting gains. This marks the second consecutive day of losses for the stock.

Tone
Negative 28/100
Event
Market update
Published
14 Jul 2026 16:30
Source
MarketWatch
MedTech Dive Direct company coverage

Medtronic recalls heart valve delivery catheter for risk of tip detaching

Medtronic has initiated a Class I recall of certain lots of its Harmony Delivery Catheter System due to the risk of the distal tip detaching during use. This issue, which affects only the delivery system and not the implanted valve, could necessitate additional procedures to remo

Tone
Negative 33/100
Event
Regulatory and legal
Published
14 Jul 2026 15:27
Source
MedTech Dive
Medtech Insight Direct company coverage

FDA Flags Medtronic Harmony Catheter Recall As Class I Over Tip Detachment

The FDA has designated the recall of Medtronic's Harmony Transcatheter Pulmonary Valve (TPV) as a Class I recall, its most serious type, due to concerns over the catheter's tip detaching. The Harmony TPV, approved in 2021, is used to treat severe pulmonary regurgitation in pediat

Tone
Negative 19/100
Event
Regulatory and legal
Published
14 Jul 2026 14:08
Source
Medtech Insight